Business
Kisses From Italy, Inc. (KITL), Announces Rapid 2026 Expansion Strategy and New Leadership Following Regen Health Physicians Combination
New York, New York--(Newsfile Corp. - April 16, 2026) - Kisses From Italy Inc. (OTC Pink: KITL) (or the "Company") today unveiled its aggressive 2026 expansion strategy and renewed leadership vision following its business combination with Regen Health Physicians, marking a transformative entry into the high-growth biologics and longevity sector.The Company also highlighted the appointment of its new CEO, Dr. Ajit Dhaliwal, MD, MBA, whose leadership is expected to drive innovation, brand...
About this update from Kisses From Italy Inc.
[{"type":"text","content":"New York, New York--(Newsfile Corp. - April 16, 2026) - Kisses From Italy Inc. (OTC Pink: KITL) (or the "Company") today unveiled its aggressive 2026 expansion strategy and renewed leadership vision following its business combination with Regen Health Physicians, marking a transformative entry into the high-growth biologics and longevity sector.","length":357,"tagName":"p"},{"type":"text","content":"The Company also highlighted the appointment of its new CEO, Dr. Ajit Dhaliwal, MD, MBA, whose leadership is expected to drive innovation, brand elevation, and national expansion initiatives. Dr. Dhaliwal earned his MD from The Royal College of Surgeons in Ireland. He completed an Internal Medicine Residency at The Mount Sinai Icahn School of Medicine in New York City. In addition, he obtained his MBA from Quantic School of Business and Technology.","length":452,"tagName":"p"},{"type":"text","content":"Dr. Dhaliwal comments: "I am incredibly excited to step into the role of CEO and lead this transformative chapter for KITL. When Jim and I first discussed this combination, what struck me immediately was the alignment - a publicly traded platform ready for a bold new direction, and a proven clinical model built to scale. Regenerative medicine and aesthetic wellness are not just trends; they are the future of how Americans will approach their health. People are demanding more. More precision, more accountability, more results - and that is exactly what Regen Health Physicians delivers.This pivot into biologics, peptide therapy, and longevity-focused care is not a pivot away from something - it is a pivot toward the most exciting growth opportunity in modern medicine. We are actively operational in New York City and Salt Lake City, with Miami and San Francisco in our sights. Our franchise and licensing model is designed to move fast and scale efficiently. I have built and exited a healthcare company before, and I know what it takes to execute. Shareholders should know that I am fully committed, deeply invested, and energized by what we are building together.The longevity revolution is no longer coming - it is here. And KITL is going to be at the center of it."","length":1292,"tagName":"p"},{"type":"text","content":"With this strategic alignment, KITL is positioning itself for rapid national scale by leveraging a prove...